1-Methyl-5-(tributylstannyl)-1H-pyrazole
Product Information
Molecular Formula
C16H32N2Sn
Molecular Weight
371.15
Description
1-Methyl-5-(tributylstannyl)-1H-pyrazole is an effective pharmaceutical intermediate. Its application in constructing emerging, effective antiviral and anti-inflammatory drugs is particularly noteworthy.
Synonyms
(1-Methyl-1H-pyrazol-5-yl)tributylstannane
IUPAC Name
tributyl-(2-methylpyrazol-3-yl)stannane
SMILES
CCCC[Sn](CCCC)(CCCC)C1=CC=NN1C
InChI
InChI=1S/C4H5N2.3C4H9.Sn/c1-6-4-2-3-5-63*1-3-4-2/h2-3H,1H33*1,3-4H2,2H3
InChI Key
MEFBHJAGBFBLEH-UHFFFAOYSA-N
Flash Point
Not applicable
Purity
97%
Density
1.160 g/mL at 25 °C
Safety Information
Hazards
H301 - H312 - H315 - H319 - H372 - H410
Precautionary Statement
P273 - P280 - P301 + P310 + P330 - P302 + P352 + P312 - P305 + P351 + P338 - P314
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
1
Rotatable Bond Count
10
Exact Mass
372.158752 g/mol
Monoisotopic Mass
372.158752 g/mol
Topological Polar Surface Area
17.8Ų
Heavy Atom Count
19
Formal Charge
0
Complexity
211
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| US-10179131-B2 | Hepatitis B antiviral agents | 2015-07-13 |
| US-10702528-B2 | Hepatitis B antiviral agents | 2015-07-13 |
| US-2017014408-A1 | Hepatitis b antiviral agents | 2015-07-13 |
| US-2019216808-A1 | Hepatitis b antiviral agents | 2015-07-13 |
| US-2016102074-A1 | Substituted amide compounds | 2014-10-08 |
| WO-2016055901-A1 | Substituted amide compounds | 2014-10-08 |
| EP-2190822-B1 | 5-membered heterocyclic compounds as proton pump inhibitors | 2007-09-28 |
| JP-2010540412-A | 5-membered heterocyclic compounds as proton pump inhibitors | 2007-09-28 |
| JP-5345140-B2 | 5-membered heterocyclic compounds as proton pump inhibitors | 2007-09-28 |
| US-2009156642-A1 | 5-Membered heterocyclic compound | 2007-09-28 |
